CCA
Cadent Capital Advisors’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $370K | Hold |
475
| – | – | 0.12% | 108 |
|
|
2025
Q1 | $392K | Hold |
475
| – | – | 0.14% | 91 |
|
|
2024
Q4 | $367K | Hold |
475
| – | – | 0.13% | 98 |
|
|
2024
Q3 | $420K | Sell |
475
-89
| -16% | -$78.8K | 0.13% | 91 |
|
|
2024
Q2 | $511K | Buy |
564
+76
| +16% | +$68.8K | 0.2% | 68 |
|
|
2024
Q1 | $380K | Hold |
488
| – | – | 0.15% | 76 |
|
|
2023
Q4 | $284K | Buy |
488
+11
| +2% | +$6.41K | 0.14% | 87 |
|
|
2023
Q3 | $256K | Buy |
477
+1
| +0.2% | +$537 | 0.11% | 98 |
|
|
2023
Q2 | $223K | Buy |
+476
| New | +$223K | 0.13% | 114 |
|